Home
Company Profile
SURGICAL ONCOLOGY
HIPEC – Hyperthermic IntraPeritoneal Chemotherapy
Isolated Organ Perfusion
Performer HT – Hyperthermic Perfusion
Publications
Congresses
Links
PRODUCTS
Performer 3
Performer HT
SERVICES
Perfusion service
MULTIMEDIA
F.A.Q.
Contacts
LANGUAGE
Deutsch
Français
Español
Italiano
The prognosis impact of hyperthermic intraperitoneal chemotherapy (HIPEC) plus cytoreductive surgery (CRS) in advanced ovarian cancer: the meta-analysis
Guyu Zhang, Yimin Zhu, Chongdong Liu, Guangming Chao, Ran Cui and Zhenyu Zhang
Prev
Next